OTC Healthcare in Serbia
Euromonitor International's OTC Healthcare in Serbia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 97 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Wider offer of expensive products increased unit price in 2008
Since during 2007 and the first half of 2008 Serbian consumers felt a notable improvement in economic conditions, they readily accepted a wave of new products launched by multinationals during the last 2-3-years of the review period. This caused increased unit prices in most OTC sectors in 2008.
Hemofarm ad uplifts its distribution network in Serbia
Two big events marked the Serbian OTC market in 2008. The first occurred in August when Nelt Co (the leading distributor of consumer goods in the Serbian market) became the official distributor of Hemofarm ad’s OTC products in the territory of Serbia. The second took place in October when the government decided to decrease prices of all drugs (including OTC drugs) by 10%. Both events will noticeably affect the industry’s performance in 2009 and beyond.
Serbian market is well covered both by multinational and domestic products
Competition among OTC producers in Serbia is well developed. Big multinational companies such as Bayer AG, Novartis, GlaxoSmithKline Plc, Reckitt Benckiser and Krka dd have been present in Serbia for decades. Domestic OTC industry is also on a respectable level with Zdravlje ad, Hemofarm ad, Galenika ad and many small producers. The high number of producers means that Serbian consumers are in a position to choose between the various brands in most OTC categories.
New distribution channels are well accepted among Serbian consumers
While OTC drugs can be sold only in authorized chemists/pharmacies from educated pharmacists, other OTC products can be found in most grocery retailers, pharmacies/drugstores, internet retailing and direct selling. During the review period, sales of OTC products increased in drugstores, hypermarkets and through specialist internet selling portals. This is not much of a surprise because these channels are relatively new in Serbia and became very popular in a short period of time.
Global economic crisis will affect the Serbian OTC market during 2009
Since experts predict that the global economic crisis will affect Serbia during 2009, the fast growth of the Serbian economy recorded in 2007 and 2008 will slow down during the first half of the forecast period. Consequently, a shift from cheap domestic to “premium” multinational OTC products will be much slower.
Serbian government controls prices of medicines
Serbian government controls prices of medicines. It sets prices of medicines based on prices in Italy, Slovenia and Croatia and the power of Serbian currency Dinar (RSD) compared to Euro (EUR).
Table of contents
OTC HEALTHCARE IN SERBIA : MARKET INSIGHT
EXECUTIVE SUMMARY
Wider offer of expensive products increased unit price in 2008
Hemofarm ad uplifts its distribution network in Serbia
Serbian market is well covered both by multinational and domestic products
New distribution channels are well accepted among Serbian consumers
Global economic crisis will affect the Serbian OTC market during 2009
Serbian government controls prices of medicines
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Generics
Switches
DEFINITIONS
Summary 1 Research Sources
ANALGESICS
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Analgesics Company Shares by Value 2004-2008
Table 15 Analgesics Brand Shares by Value 2005-2008
Table 16 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 20 Sales of Decongestants by Type: Value 2003-2008
Table 21 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 24 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 29 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 30 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 31 Herbal vs Standard Digestive Remedies 2003-2008
Table 32 Digestive Remedies Company Shares by Value 2004-2008
Table 33 Digestive Remedies Brand Shares by Value 2005-2008
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 36 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 37 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 38 Herbal vs Standard Medicated Skin Care 2003-2008
Table 39 Medicated Skin Care Company Shares by Value 2004-2008
Table 40 Medicated Skin Care Brand Shares by Value 2005-2008
Table 41 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 42 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 43 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 44 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 46 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 47 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 48 Vitamins Brand Shares by Value 2005-2008
Table 49 Dietary Supplements Brand Shares by Value 2005-2008
Table 50 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS
EYE CARE
Sector Data
Table 52 Sales of Eye Care by Subsector: Value 2003-2008
Table 53 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 54 Eye Care Company Shares by Value 2004-2008
Table 55 Eye Care Brand Shares by Value 2005-2008
Table 56 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 57 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
WOUND TREATMENTS
Sector Data
Table 58 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 59 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 60 Wound Treatments Company Shares by Value 2004-2008
Table 61 Wound Treatments Brand Shares by Value 2005-2008
Table 62 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 63 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
EAR CARE
Sector Data
Table 64 Sales of Ear Care: Value 2003-2008
Table 65 Sales of Ear Care: % Value Growth 2003-2008
Table 66 Ear Care Company Shares by Value 2004-2008
Table 67 Ear Care Brand Shares by Value 2005-2008
Table 68 Forecast Sales of Ear Care: Value 2008-2013
Table 69 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE
Headlines
Sector Data
Table 70 Sales of Adult Mouth Care: Value 2003-2008
Table 71 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 72 Adult Mouth Care Company Shares by Value 2004-2008
Table 73 Adult Mouth Care Brand Shares by Value 2005-2008
Table 74 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 75 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS
Sector Data
Table 76 Sales of Calming and Sleeping Products: Value 2003-2008
Table 77 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 78 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 79 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 80 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 81 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
EMERGENCY CONTRACEPTION
Sector Data
Table 82 Sales of Emergency Contraception: Value 2004-2008
Table 83 Sales of Emergency Contraception: % Value Growth 2004-2008
Table 84 Emergency Contraception Company Shares by Value 2004-2008
Table 85 Emergency Contraception Brand Shares by Value 2005-2008
Table 86 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 87 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013
OTC OBESITY
OTC TRIPTANS
GALENIKA AD
Strategic Direction
Key Facts
Summary 2 Galenika ad: Key Facts
Summary 3 Galenika ad: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 4 Galenika ad: Competitive Position 2008
HEMOFARM AD
Strategic Direction
Key Facts
Summary 5 Hemofarm ad: Key Facts
Summary 6 Hemofarm ad: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Hemofarm ad: Competitive Position 2008
ZDRAVLJE-LESKOVAC PHARMACEUTICAL & CHEMICAL INDUSTRY
Strategic Direction
Key Facts
Summary 8 Zdravlje-Leskovac Pharmaceutical & Chemical Industry: Key Facts
Summary 9 Zdravlje-Leskovac Pharmaceutical & Chemical Industry: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Zdravlje-Leskovac Pharmaceutical & Chemical Industry: Competitive Position 2008